Form 4: AnaptysBio Director Dennis Fenton Sells 1,950 Shares Under 10b5-1 Trading Plan

Director Dennis Fenton sold 1,950 shares of AnaptysBio (ANAB) common stock at $23.17 per share on June 21, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On June 21, 2024, Dennis M Fenton, a director of AnaptysBio, Inc. (ANAB), sold 1,950 shares of common stock.
• The shares were sold at a price of $23.17 per share.
• The sale was executed under a Rule 10b5-1 trading plan adopted on March 22, 2024.
• Following the transaction, Fenton directly owns 1,950 shares of AnaptysBio common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-arranged trading plan. There is no indication of positive or negative implications for the company's performance.

Industry Context

Sales by company directors are a normal part of corporate governance. The fact that this sale was executed under a 10b5-1 trading plan suggests it was pre-planned and not based on any immediate inside information.

Stakeholder Impact

• The sale of shares by a director could have a minor negative impact on shareholder sentiment, but the effect is likely to be minimal given the relatively small number of shares sold and the existence of a pre-arranged trading plan.

Key Dates